tiprankstipranks
Oryzon Genomics SA (DE:ORN)
FRANKFURT:ORN
Germany Market
ORN
Oryzon Genomics SA
RESEARCH TOOLSreports

Oryzon Genomics SA (ORN) Financial Statements

Compare
1 Followers

Oryzon Genomics SA Financial Overview

Oryzon Genomics SA's market cap is currently €211.33M. The company's EPS TTM is €-0.02; its P/E ratio is -88.77; Oryzon Genomics SA is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is €-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 0.00€ 7.36M€ 0.00€ 0.00€ 10.62M
Gross Profit€ -133.91K€ 7.06M€ 13.95M€ 15.23M€ 9.87M
Operating Income€ -6.42M€ -4.42M€ -4.55M€ -5.49M€ -7.01M
EBITDA€ -6.29M€ -4.43M€ -4.43M€ -5.35M€ -6.88M
Net Income€ -2.61M€ -3.67M€ -3.35M€ -4.23M€ -4.69M
Balance Sheet
Cash & Short-Term Investments€ 28.37M€ 5.62M€ 12.26M€ 21.32M€ 28.72M
Total Assets€ 144.52M€ 108.72M€ 106.90M€ 103.70M€ 95.38M
Total Debt€ 11.94M€ 16.21M€ 13.69M€ 17.44M€ 17.52M
Net Debt€ -16.41M€ 10.59M€ 1.43M€ -3.88M€ -14.95M
Total Liabilities€ 26.68M€ 21.67M€ 25.13M€ 31.13M€ 24.12M
Stockholders' Equity€ 105.45M€ 87.04M€ 81.77M€ 72.57M€ 71.26M
Cash Flow
Free Cash Flow€ -2.42M€ -13.40M€ -15.08M€ -16.12M€ -15.39M
Operating Cash Flow€ -2.36M€ -5.69M€ -574.96K€ -1.85M€ -3.63M
Investing Cash Flow€ -11.04M€ -7.81M€ -14.50M€ -14.27M€ -11.72M
Financing Cash Flow€ 36.13M€ 6.87M€ 6.02M€ 8.71M€ 4.12M
Currency in EUR

Oryzon Genomics SA Earnings and Revenue History

Income Statement >

Oryzon Genomics SA Debt to Assets

Balance Sheet >

Oryzon Genomics SA Cash Flow

Cash Flow >

Oryzon Genomics SA Forecast EPS vs Actual EPS

Earnings >